Evidence map›Paper›PMID 38658427›Full record

ArticleFood and environmental virology2024

Environmental Surveillance of Poliovirus and Non-polio Enteroviruses in Iran, 2017-2023: First Report of Imported Wild Poliovirus Type 1 Since 2000.

Ahmad Nejati, Seyed Mehdi Tabatabaei, Sussan Mahmoudi, Seyed Mohsen Zahraei, Hamideh Tabatabaie, Mohammad Razaghi, Farshad Khodakhah, Maryam Yousefi, Yaghoub Mollaei-Kandelousi, Maryam Keyvanlou and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Food and environmental virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ahmad NejatiNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Mehdi TabatabaeiHealth Promotion Research Center, Zahedan University of Medical Sciences, Sistan Balouchestan Province, Zahedan, Iran.
Sussan MahmoudiVaccine Preventable Diseases Department, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Seyed Mohsen ZahraeiVaccine Preventable Diseases Department, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Hamideh TabatabaieNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad RazaghiNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Farshad KhodakhahNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Maryam YousefiNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Yaghoub Mollaei-KandelousiNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Maryam KeyvanlouNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Parastoo SoheiliNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Shayan PouyandehNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Katayoon Samimi-RadNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Shohreh ShahmahmoodiNational Polio Laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. shahmahmoodi@tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Iran, which is at high risk of the Wild Poliovirus (WPV) and Vaccine-Derived Poliovirus (VDPV) importation due to its neighborhood with two polio endemic countries, Pakistan and Afghanistan, Environmental Surveillance (ES) was established in November 2017. Sistan-Balouchestan province was chosen for the ES due to its vicinity with Pakistan and Afghanistan. Five sewage collection sites in 4 cities (Zahedan, Zabol, Chabahar and Konarak) were selected in the high-risk areas. Since the establishment of ES in November 2017 till the end of 2023, 364 sewage specimens were collected and analyzed. The ES detected polioviruses which have the highest significance for polio eradication program, that is, Wild Poliovirus type 1 (WPV1) and Poliovirus type 2 (PV2). In April and May 2019, three of 364 (0.8%) sewage specimens from Konarak were positive for imported WPV1. According to phylogenetic analysis, they were highly related to WPV1 circulating in Karachi (Sindh province) in Pakistan. PV2 was also detected in 5.7% (21/364) of the sewage specimens, most of which proved to be imported from the neighboring countries. Of 21 isolated PV2s, 7 were VDPV2, of which 5 proved to be imported from the neighboring countries as there was VDPV2 circulating in Pakistan at the time of sampling, and 2 were ambiguous VDPVs (aVDPV) with unknown source. According to the findings of this study, as long as WPV1 and VDPV2 outbreaks are detected in Iran's neighboring countries, there is a definite need for continuation and expansion of the environmental surveillance.

Indexed as

EnterovirusEnvironmental MonitoringPhylogenyPoliomyelitisPoliovirusSewageEnterovirus InfectionsHumansIranSewageEnvironmental surveillanceIranPoliovirusVaccine-derived poliovirusWild poliovirus type 1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.